Global Virus Filtration Market Is Estimated To Witness High Growth Owing To Increasing Demand for Effective Viral Removal Solutions
![]() |
Virus Filtration Market |
The global Virus Filtration Market is estimated to be valued at US$ 4.44 Bn in 2022 and is expected to exhibit a CAGR of 14.3% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Virus filtration is a critical process in biopharmaceutical manufacturing to
ensure the safety and purity of therapeutic products. It is used to remove
viruses and other potential contaminants from biologics, vaccines, blood and
blood products, and other biological products. The market for virus filtration
is driven by the increasing demand for effective viral removal solutions,
stringent regulations for product safety, and the growing biopharmaceutical industry.
Market Key Trends:
One key trend in the Virus Filtration Market is the increasing adoption of
single-use filtering systems. Single-use systems offer several advantages such
as reducing cross-contamination risks, improving process efficiency, and eliminating
the need for cleaning and validation. These systems provide cost-effective
solutions for small-scale production and are widely used in research
laboratories and contract manufacturing organizations.
For example, Wuxi Biologics, a leading global contract development and
manufacturing organization (CDMO), offers a single-use virus filtration system
called Viresolve NFF Virus Filters. This system provides high viral clearance
and is suitable for a wide range of applications, including vaccines, gene therapies,
and monoclonal antibodies.
PEST Analysis:
- Political: The virus filtration market is subject to various regulations and
guidelines by regulatory authorities such as the U.S. Food and Drug
Administration (FDA) and the European Medicines Agency (EMA). These regulations
aim to ensure the safety and efficacy of biopharmaceutical products.
- Economic: The growing biopharmaceutical industry and increasing investment in
research and development activities drive the demand for virus filtration
products.
- Social: The increasing awareness about product safety and the need for
effective virus removal solutions contribute to market growth.
- Technological: Advancements in filtration technologies, such as the
development of high-capacity filters and improved virus clearance rates,
enhance the efficiency and effectiveness of virus filtration processes.
Key Takeaways:
- The global
Virus Filtration Market is expected to witness high growth, exhibiting
a CAGR of 14.3% over the forecast
period, due to increasing demand for effective viral removal solutions.
Stringent regulations for product safety further drive market growth.
- North America is the fastest growing and dominating region in the Virus
Filtration Market, attributed to the presence of a well-established
biopharmaceutical industry, advanced healthcare infrastructure, and the
adoption of technologically advanced filtration systems.
- Key players operating in the global Virus Filtration Market include Wuxi
Biologics, Clean Cell Inc., Sartorius AG, Pall Corporation, Merck KgaA, Lonza
Group Ltd., General Electric Company, Thermo Fischer Scientific Inc., Asahi
Kasei Medical Co. Ltd., and Charles River Laboratories International Inc. These
players focus on strategic collaborations, product launches, and mergers and
acquisitions to strengthen their market position and expand their product
portfolios.
In conclusion, the global Virus Filtration Market is experiencing significant
growth due to the increasing demand for effective virus removal solutions in
the biopharmaceutical industry. The adoption of single-use filtering systems is
a key trend in the market. Regulatory compliance, economic factors, societal
awareness, and technological advancements also contribute to market growth.
North America is the fastest growing region, and key players in this market
include Wuxi Biologics, Clean Cell Inc., Sartorius AG, Pall Corporation, Merck
KgaA, Lonza Group Ltd., General Electric Company, Thermo Fischer Scientific
Inc., Asahi Kasei Medical Co. Ltd., and Charles River Laboratories
International Inc.
Comments
Post a Comment